STUDY OF INFECTIOUS COMPLICATIONS IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB

被引：0
|
作者：
Diaz, Galvez Francisco J. [1 ]
Barrigon Fernando, Escalante [2 ]
Vals Julio, Davila [3 ]
Saavedra Veronica, Campuzano [1 ]
Gomez Jorge, Labrador [1 ]
Garcia Abelardo, Barez [3 ]
Maria Del Carmen, Hermoso Martinez [3 ]
Nuno Rodolfo, Alvarez [1 ]
机构：
[1] Hosp Univ Burgos, Burgos, Spain
[2] Complejo Asistencial Univ Leon, Leon, Spain
[3] Complejo Asistencial Avila, Avila, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-015
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [21] HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH MULTIPLE MYELOMA (MM) TREATED WITH DARATUMUMAB. EXPERIENCE IN A CENTER
    Gonzalo, Benzo
    Beatriz, Aguado
    Isabel, Vicuna
    Carlota, Mayor
    Ana, Puchol
    Sofia, Diaz
    Carmen, Jimenez-Montes
    Ahlam, Serroukh
    Adrian, Alegre
    HAEMATOLOGICA, 2021, 106 (10) : 139 - 139
  • [22] PATIENTS WITH MULTIPLE MYELOMA TREATED WITH DARATUMUMAB IN COMBINATION. EXPERIENCE IN SINGLE CENTER
    Robredo Rodriguez, B.
    Villanueva Jimenez, P.
    Quesada Sanz, M.
    Sanchez Garcia, M., I
    Delgado Mateos, F.
    Avila Alvarez, J. R.
    Casaus Garcia, A.
    HAEMATOLOGICA, 2019, 104 : 397 - 397
  • [23] Infectious risks in newly diagnosed multiple myeloma (NDMM) patients receiving (or treated with) daratumumab based regimens: a multicentric Italian experience
    Rago, Angela
    Fioritoni, Francesca
    Offidani, Massimo
    Annibali, Ombretta
    Poggiali, Roberta
    Za, Tommaso
    Franceschini, Luca
    De Padua, Laura
    Piciocchi, Alfonso
    Fiorini, Alessia
    di Toritto, Tommaso Caravita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S150 - S150
  • [24] Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid+/- Corticosteroids).
    Kukreti, Vishal
    Masih-Khan, Esther
    Dean, Saima
    Kumar, Deepali
    Mikhael, Joseph R.
    Trudel, Suzanne
    Reece, Donna E.
    Chen, Christine
    BLOOD, 2009, 114 (22) : 1123 - 1123
  • [25] Infectious toxicities in patients treated with bispecific antibodies in multiple myeloma
    Saez, Adolfo
    Lopez-Munoz, Nieves
    Maria Sanchez-Pina, Jose
    Alonso, Rafael
    Cuellar, Clara
    Lazaro, Paula
    Jimenez Ubieto, Ana
    Calbacho, Maria
    Martinez Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S97 - S98
  • [26] Mechanisms of resistance to daratumumab in patients with multiple myeloma
    Iversen, Katrine Fladeland
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (04) : 401 - 408
  • [27] Daratumumab in multiple myeloma
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Hofmeister, Craig C.
    Joseph, Nisha S.
    Heffner, Thomas L.
    Gupta, Vikas A.
    Sullivan, Harold C.
    Neish, Andrew S.
    Dhodapkar, Madhav, V
    Lonial, Sagar
    CANCER, 2019, 125 (14) : 2364 - 2382
  • [28] Infectious Complications and Their Relationship with Mortality in Patients Newly Diagnosed with Multiple Myeloma
    Luis Ontiveros, Juan Luis
    Rajme-Lopez, Sandra
    Orozco, Alfonso
    Rodriguez-Rodriguez, Sergio
    Riviello-Goya, Santiago
    Seidman-Sorsby, Alec
    Aguayo, Alvaro
    Martinez-Banos, Deborah
    BLOOD, 2022, 140 : 12508 - 12509
  • [29] Daratumumab in multiple myeloma
    Rajkumar, S. Vincent
    LANCET, 2016, 387 (10027): : 1490 - 1492
  • [30] Daratumumab for multiple myeloma
    Croizier, Carolyne
    Bailly, Sebastien
    BULLETIN DU CANCER, 2018, 105 (11) : 985 - 991
12345